{"schema_version":"secwatch.filing_event.v1","accession":"0001612630-26-000048","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.592538+00:00","generated_at":"2026-05-14T21:47:02.629611+00:00","sec_items":["1.01","2.03","2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"JYNT Q1 revenue up 13%, net income up 34%; credit covenant default waived","bullets":["Revenue $14.8M (+13% YoY); net income from continuing ops $1.1M vs loss $506K prior year.","Consolidated diluted EPS $0.09 (vs $0.06); Adj EBITDA from consolidated ops $3.5M (+22%).","Credit default waived for fixed charge coverage ratio violation; JPM line extended to Aug 2029, $20M undrawn.","System-wide comp sales -4.2%; total clinic count 943 (down 17 vs Q4 2025).","Refranchised 45 clinics to Elite Chiro Group for $2.3M; repurchased 137K shares for $1.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0001612630-26-000048","json":"https://secwatch.observer/filing/0001612630-26-000048.json","markdown":"https://secwatch.observer/filing/0001612630-26-000048.md","text":"https://secwatch.observer/filing/0001612630-26-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/0001612630-26-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/jynt-20260501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:47:02.629611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f7c5b8cfcb3501422ee7259487d0680e4f404901","claim":"JOINT Corp amended revolving credit with JPMorgan Chase Bank, N.A. maturing August 31, 2029.","evidence_excerpt":"waiver and fourth amendment to our existing credit agreement (the “2026 Amendment”) with JPMorgan Chase Bank, N.A., individually and as Administrative Agent, Issuing Bank, and Lender (“JPMorgan Chase” or the “Lender”). Among other things, the 2026 Amendment waives the existing default of our credit facilities due to a violation of our fixed charge coverage ratio covenant, modifies the fixed charge coverage ratio covenant to allow for stock repurchases, which constitute restricted payments, and extends the revolving credit maturity date to August 31, 2029.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/0001612630-26-000048-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A."},{"label":"Maturity","value":"August 31, 2029"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"d23ce1236b83e5512557bb3e383e8f7243e051aa","claim":"JOINT Corp reported the first quarter ended March 31, 2026 results: revenue $14.8 million, net income $1.3 million, EPS $0.09 per diluted share.","evidence_excerpt":"first quarter ended March 31, 2026. The following figures represent continuing operations unless otherwise stated . First Quarter 2026 Financial Highlights • Grew revenues to $14.8 million, a 13% increase compared to the first quarter of 2025. • Reported system-wide sales 1 of $126.1 million, a decline of 4.9%. • Reported comp sales 2 of (4.2)%. • Net income from","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000161263026000048/0001612630-26-000048-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$14.8 million"},{"label":"Net income","value":"$1.3 million"},{"label":"EPS","value":"$0.09 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}